Top Markets
Coin of the day
Oncotelic Therapeutics, Inc. Oncotelic Therapeutics, Inc.

Oncotelic Therapeutics, Inc.

OTLC
Pozycja w akcjach #30398
Oncotelic Therapeutics, Inc., an Agoura Hills, California-based clinical-stage... Oncotelic Therapeutics, Inc., an Agoura Hills, California-based clinical-stage biopharmaceutical company, specializes in developing therapeutics for rare oncological conditions. Its flagship therapeutic candidate, OT-101 – an antisense compound designed to inhibit TGF-ß2 – is currently undergoing Phase 3 clinical trials for both pancreatic cancer and glioblastoma. Beyond oncology, OT-101 is also being explored for its potential in treating various viral diseases, including severe acute respiratory syndrome (SARS) and coronaviruses. The company's pipeline further includes OXi4503, which is being advanced for acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), and CA4P, intended for the treatment of advanced metastatic melanoma.
Cena akcji
$0.03834
Ostatnia synchronizacja: 2026-08-18
Kapitalizacja rynkowa
$17.01M
Zmiana (1 dzień)
-4.15%
Zmiana (1 rok)
-24.82%
Kraj
US
Handel Oncotelic Therapeutics, Inc. (OTLC)

Kategoria

Historia ceny akcji dla Oncotelic Therapeutics, Inc. (OTLC)
Najwyższa cena zamknięcia: $0.04 dnia 2026-08-01

Najniższa cena zamknięcia: $1.13K dnia 1993-08-01
Historia cen akcji firmy Oncotelic Therapeutics, Inc. od 1993 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -32.69%
2025 190.53%
2024 -20.32%
2023 -22.41%
2022 -69.52%
2021 -23.89%
2020 10.12%
2019 94.22%
2018 -42.06%
2017 -52.99%
2016 -55.78%
2015 -50.20%
2014 -33.92%
2013 -46.34%
2012 -62.10%
2011 -75.63%
2010 -81.77%
2009 63.41%
2008 -70.61%
2007 -50.93%
2006 16.57%
2005 -22.97%
2004 -35.60%
2003 628.33%
2002 -57.82%
2001 -63.45%
2000 -53.89%
1999 80.93%
1998 -47.29%
1997 -25.80%
1996 133.79%
1995 86.60%
1994 -25.42%
1993 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$527.89 35.09%
US
$996.61 51.72%
NL
$116.13 -20.22%
AU
$735.86 6.07%
CH
$257.75 14.92%
BE